Related Experiment Video
Updated: Feb 14, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Effect of probiotic treatment on cirrhotic patients with minimal hepatic encephalopathy: A meta-analysis
Qing Cao1, Cheng-Bo Yu1, Shi-Gui Yang1
1State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
Background:
Minimal hepatic encephalopathy (MHE) is an early and reversible form of hepatic encephalopathy. The documentations on the treatment with probiotics are inconsistent. The present meta-analysis was to verify the role of probiotics in the treatment of cirrhotic patients with MHE.
Data Sources:
Seven electronic databases were searched for relevant randomized controlled trials (RCTs) published until July 2015. The effects of probiotics on serum ammonia, endotoxin, and MHE were evaluated.
Results:
A total of 14 RCTs (combined n = 1132) were included in the meta-analysis. When probiotics were compared to placebo or no treatment, probiotics were more likely to reduce values in the number connection test (NCT; week 4: MD = -30.25, 95% CI: -49.85 to -10.66), improve MHE (week 4: OR = 0.18, 95% CI: 0.07 to 0.47; week 12: OR = 0.15, 95% CI: 0.07 to 0.32), and prevent overt HE progression (week 4: OR = 0.22, 95% CI: 0.07 to 0.67) in patients with liver cirrhosis. When probiotics was compared to lactulose, probiotics tended to reduce serum ammonia levels (week 4: MD = -0.33 µmol/L, 95% CI: -5.39 to 4.74; week 8: MD = 6.22 µmol/L, 95% CI: -24.04 to 36.48), decrease NCT (week 8: MD = 3.93, 95% CI: -0.72 to 8.58), improve MHE (week 4: OR = 0.93, 95% CI: 0.45 to 1.91; week 12: OR = 0.73, 95% CI: 0.35 to 1.51) and prevent the development of overt HE (week 4: OR = 0.96, 95% CI: 0.17 to 5.44; week 12: OR = 2.7, 95% CI: 0.50 to 14.64) in patients with liver cirrhosis. However, lactulose appears to be more effective in reducing NCT values as compared to probiotics (week 4: MD = 6.7, 95% CI: 0.58 to 12.82).
Conclusion:
Probiotics can decrease serum ammonia and endotoxin levels, improve MHE, and prevent overt HE development in patients with liver cirrhosis.
Insights
Probiotics show promise in treating minimal hepatic encephalopathy (MHE) in liver cirrhosis patients. This meta-analysis found probiotics can reduce ammonia and endotoxin levels, improving MHE and preventing overt hepatic encephalopathy (HE).
Area of Science:
- Gastroenterology and Hepatology
- Microbiology
- Clinical Nutrition
Background:
- Minimal hepatic encephalopathy (MHE) is an early, reversible stage of hepatic encephalopathy (HE).
- Existing research on probiotic treatment for MHE in cirrhotic patients yields inconsistent results.
- This meta-analysis aims to clarify the efficacy of probiotics in managing MHE among patients with liver cirrhosis.
Purpose of the Study:
- To systematically evaluate the effectiveness of probiotics in treating cirrhotic patients diagnosed with minimal hepatic encephalopathy (MHE).
- To assess the impact of probiotics on key indicators such as serum ammonia, endotoxin levels, and MHE status.
Main Methods:
- A comprehensive meta-analysis of randomized controlled trials (RCTs) was conducted.
- Searches were performed across seven electronic databases for studies published up to July 2015.
- The analysis included 14 RCTs involving 1132 patients, comparing probiotics against placebo/no treatment and lactulose.
Main Results:
- Probiotics significantly improved MHE and reduced Number Connection Test (NCT) scores compared to placebo.
- Probiotics also demonstrated a trend towards preventing overt HE progression compared to placebo.
- While probiotics showed some benefits, lactulose appeared more effective in reducing NCT values in certain comparisons.
Conclusions:
- Probiotics are effective in reducing serum ammonia and endotoxin levels in liver cirrhosis patients.
- Probiotic supplementation can improve minimal hepatic encephalopathy (MHE) and prevent the progression to overt hepatic encephalopathy (HE).
- Further research may be needed to directly compare the long-term efficacy of probiotics versus lactulose for MHE management.
More Related Videos
Related Concept Videos
Directing Effect of Substituents: meta-Directing Groups
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
meta-Directing Deactivators: –NO2, –CN, –CHO, –⁠CO2R, –COR, –CO2H
Types of Errors: Detection and Minimization
Absolute error in a measurement is the numerical difference from the true or central value. Relative error is the ratio between absolute error and the true or central value, expressed as a percentage.
Errors can be classified by source, magnitude, and sign. There are three types of errors: systematic, random, and gross.
Systematic or...

